Tag: MindMed - Page 6 - Psychedelic Alpha

Read more about the article MindMed To Commence Trading on Nasdaq

MindMed To Commence Trading on Nasdaq

Post published:April 23, 2021
Post category:Press Release

Read more about the article MindMed Announces the Publication of New Data on Personalized MDMA Dosing

MindMed Announces the Publication of New Data on Personalized MDMA Dosing

Post published:April 5, 2021
Post category:Press Release

Read more about the article MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

Post published:March 30, 2021
Post category:Press Release

Read more about the article MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

Post published:March 30, 2021
Post category:Press Release

Read more about the article MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

Post published:March 29, 2021
Post category:Press Release

Read more about the article MindMed Announces Inclusion in FTSE Russell Indexes

MindMed Announces Inclusion in FTSE Russell Indexes

Post published:March 22, 2021
Post category:Press Release

Read more about the article MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

Post published:March 9, 2021
Post category:Press Release

Read more about the article MindMed Announces C$19.5 Million Bought Deal Private Placement Offering

MindMed Announces C$19.5 Million Bought Deal Private Placement Offering

Post published:March 8, 2021
Post category:Press Release

Read more about the article MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 26, 2021
Post category:Press Release

Read more about the article MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 18, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.